VivoSeq
Metabolic & Endocrine

Overweight , Obesity

1

Pipeline Programs↗

2

Active Trials↗

3

Companies Involved↗

Overweight , Obesity is an early-stage landscape with 1 program across 3 companies. The most active players are Beijing QL Biopharmaceutical Co.,Ltd, Moon (Guangzhou) Biotechnology Co., Ltd., Eli Lilly.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

B

Beijing QL Biopharmaceutical Co.,Ltd

2 programs

Phase 1M

Moon (Guangzhou) Biotechnology Co., Ltd.

1 program

PreclinicalEli Lilly logo

Eli Lilly

1 program

Preclinical

Pipeline

Programs by Phase

Preclinical1

AKM Lab-01

Moon (Guangzhou) Biotechnology Co., Ltd.

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

3

clinical trials

Recruiting2 · 67%
Completed1 · 33%

Clinical Trials

Trial Activity

Research on the Needs, Feasibility, and Intervention Effects of AI Health Coach-based Just-in-Time Adaptive Intervention (JITAI) in Weight Management for Overweight/Obese Adults
Completed·TThe Fourth Affiliated Hospital of Zhejiang University School of Medicine·Preclinical·NCT07682571·31 enrolled
A Randomized, Double-blind, Placebo-controlled Trial to Access the Efficacy and Safety of Akkermansia Muciniphila AKM Lab-01 in Participents With Overweigh and Obesity
Recruiting·MMoon (Guangzhou) Biotechnology Co., Ltd.·Preclinical·NCT07331974·200 enrolled
A Drug-drug Interaction Study to Evaluate the Impact of Multiple Subcutaneous Injections of ZT002 on the Pharmacokinetics of Metformin, Warfarin, Rosuvastatin and Digoxin in Overweight and Obese Participants
Recruiting·BBeijing QL Biopharmaceutical Co.,Ltd·Phase 1·NCT07550816·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)